Also trades as: APLLTD.BO (BSE) · $vol 0M
APLLTD.NS NSE
Alembic Pharmaceuticals Limited
1W: -4.5%
1M: -1.9%
3M: -2.6%
YTD: -6.5%
1Y: -14.3%
3Y: +44.0%
5Y: -18.5%
₹753.25 ($7.87)
+4.35 (+0.58%)
Weekly Expected Move ±4.2%
₹715
₹748
₹781
₹814
₹847
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹148.5B ($1.6B)
52W Range635.8-1107.9
Volume192,657
Avg Volume124,680
Beta0.88
Dividend₹11.00
Analyst Ratings
No analyst coverage
Company Info
CEOChirayu Ramanbhai Amin
Employees14,858
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2011-09-20
Websitealembicpharmaceuticals.com
Alembic Road
Vadodara 390003
IN
Vadodara 390003
IN
91 26 5228 0550
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found